Back to Results

VA Protocol: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Study category: Behaviors and Mental Health

Is this Study for You?

Let's Get Started!

Description

Adults diagnosed with schizophrenia are needed for a clinical trial to learn more about how a new medication may affect the brain. Study participants will complete MRI scans, clinical interviews, and cognitive tests. Duration of participation: 14 weeks. Participants will be compensated for their time.

Details
Age

Adult

Eligibility

Volunteers must have a diagnosis of schizophrenia or schizoaffective disorder.

Detailed Eligibility: Volunteers must be between 18-70 years old, have a diagnosis of schizophrenia or schizoaffective disorder, not have metal or electronic devices in their body and not be claustrophobic.

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Jason Tregellas

Jason Tregellas

Study ID

Protocol Number: 16-1831

More information available at ClinicalTrials.gov: NCT03034356

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers